Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01668771 · ClinicalTrials.gov registry record

Self-Affirmation and Response to Health Risk Information

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
1,116
Enrollment target

NCT01668771: Completed study, sponsored by National Cancer Institute (NCI).

NCT01668771 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,116 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01668771 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
1,116 participants
Enrollment target

Study Summary

Background: \- Self-affirmation is the process of reflecting on values that a person considers important. This process may encourage people to be more open to information about health risks. It may also encourage them to change their behaviors or lifestyle to decrease these health risks. Researchers want to look at the effect of self-affirmation on people s responses to new health risk information. Because recent studies have linked alcohol consumption to increased risk of breast cancer, the study will focus on alcohol s link to breast cancer. Objectives: \- To study how self-affirmation can change opinions following a message about a health risk. Eligibility: \- Women at least 18 years of age who drink at least two alcoholic beverages per week and/or at least three alcoholic beverages per sitting. Design: * Participants will be recruited through an online panel. The study will be conducted entirely online. * Participants will respond to two short studies. The first will ask about life events and how they make people feel. The second will look at how people respond to information about alcohol and breast cancer. * For the first study, participants will write a paragraph or two about an important event in their lives. They will answer questions about how that event made them feel. They will also write a paragraph about an important personal value. * For the second study, participants will read information about alcohol and breast cancer risk. They will then answer questions about this information. They will also answer questions about their beliefs about alcohol and breast cancer. * Participants will receive financial compensation for being in this study.

Trial Details

FieldValue
Enrollment Target 1,116 participants
Start Date 2012-08-11
Est. Completion 2013-05-13
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT01668771 record still lists

NCT01668771 is an observational study that tracks outcomes without assigning an intervention. Its 1,116 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01668771 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01668771 about?

NCT01668771 is a clinical study titled "Self-Affirmation and Response to Health Risk Information". Background: \- Self-affirmation is the process of reflecting on values that a person considers important. This process may encourage people to be more open to information about health risks. It may also encourage them to change their behaviors or lifestyle to decrease these health risks. Researcher...

What is the current status of trial NCT01668771?

This trial is currently completed. The enrollment target is 1,116 participants. The study started on 2012-08-11. Estimated completion is 2013-05-13.

Who is sponsoring clinical trial NCT01668771?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02140255 · 1,120 participants · Phase 1

    Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

  • NCT06618534 · 1,120 participants · Phase 2

    Azithromycin for Meningococcal Carriage

  • NCT07164131 · 1,120 participants · Phase 4

    Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

  • NCT05691478 · 1,122 participants · Phase 2

    A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01668771, the US trial registry maintained by the National Library of Medicine. NCT01668771 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.